심장 보철 기기 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global cardiac prosthetic devices market size is expected to reach USD 21.21 Billion in 2034 from USD 9.88 Billion in 2025, growing at a CAGR of 8.86 during 2026-2034.This market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and the increasing aging population worldwide. Cardiac prosthetic devices, including heart valves, pacemakers, and ventricular assist devices, are essential for managing complex heart conditions and improving patient survival rates. Advancements in medical technology and surgical techniques have enhanced the safety and effectiveness of these devices, encouraging wider adoption. Additionally, improved diagnostic capabilities are enabling early detection of heart disorders, further supporting market expansion.

Key drivers include increasing healthcare expenditure, growing awareness about cardiac health, and continuous innovation in device design. Minimally invasive procedures and transcatheter technologies have gained popularity, reducing recovery time and improving patient outcomes. The expansion of healthcare infrastructure, particularly in emerging economies, is also contributing to the market's growth. Furthermore, collaborations between medical device companies and research institutions are accelerating the development of next-generation cardiac prosthetic solutions.

Future prospects for this market remain promising, with ongoing advancements in biomaterials and digital health integration. The development of smart and connected devices capable of real-time monitoring is expected to transform cardiac care. Emerging markets are likely to provide significant growth opportunities due to increasing access to advanced treatments. As the global burden of heart disease continues to rise, the cardiac prosthetic devices market is poised for sustained expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

• Pacemaker (Implantable Pacemaker, External Pacemakers)
• Heart Valves (Mechanical Heart Valve, Tissue Heart Valve, Transcatheter Heart Valve)

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Abbott Laboratories, Abiomed, AtriCure, Biotronik, Boston Scientific Corporation, CryoLife, Edwards Lifesciences Corporation, Labcor Laboratorios, Lepu Medical Technology, Lifetech Scientific, LivaNova, Medtronic, Meril Life Sciences, MicroPort Scientific, Siemens Healthineers

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation Data Visualization
  • 1.3.3 Data Validation Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Pacemaker (Implantable Pacemaker, External Pacemakers) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Heart Valves (Mechanical Heart Valve, Tissue Heart Valve, Transcatheter Heart Valve) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET: BY REGION 2022-2034 (USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 Rest of Latin America
• 6.6. Middle East Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain Channel Partners (based on availability)
• 7.4. Market Share Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CARDIAC PROSTHETIC DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 Abiomed
  • 8.2.3 AtriCure
  • 8.2.4 Biotronik
  • 8.2.5 Boston Scientific Corporation
  • 8.2.6 CryoLife
  • 8.2.7 Edwards Lifesciences Corporation
  • 8.2.8 Labcor Laboratorios
  • 8.2.9 Lepu Medical Technology
  • 8.2.10 Lifetech Scientific
  • 8.2.11 LivaNova
  • 8.2.12 Medtronic
  • 8.2.13 Meril Life Sciences
  • 8.2.14 MicroPort Scientific
  • 8.2.15 Siemens Healthineers